INS and Insulin resistance: A higher dose (at least above 25 g/day) intake of EVOO with an average duration of above 8 weeks significantly decreased insulin (SMD = −0.28, 95% CI: −0.51, −0.05) and homeostatic model assessment for insulin resistance (HOMA‐IR) (SMD = −0.19, 95% CI: −0.35, −0.03) (Morvaridzadeh et al. 2023).